Diatrizoate Meglumine And Diatrizoate Sodium Solution
Product Images NDC 53041-690

This is a description of a medication with the NDC code 53041-688-03. The medication contains 37% organically bound iodine and is made up of diatrizoate meglumine and diatrizoate sodium. It is a solution intended for oral or rectal use only, and is not meant to be injected. It is used for gastrointestinal radiography and comes in a single dose bottle of 120 mL. The standard dosage is provided on the package insert. Each mL of the solution provides 660 mg of diatrizoate meglumine and 100 mg diatrizoate sodium, adjusted to a pH of 6.0 - 7.6 with sodium hydroxide, and contains 367 mg of organically bound iodine. The medication should be stored at 20-25°C, in a tight, light-resistant container, and protected from excessive heat. It is manufactured by Guardian Drug Company, located in Dayton, New Jersey. The expiration date (EXP) is not provided.*

This is a description of Diatrizoate Meglumine and Diatrizoate Sodium Solution for oral or rectal use only. It contains 37% Organically Bound Iodine and is not for parenteral use. Each mL of the solution provides 660 mg diatrizoate meglumine and 100 mg diatrizoate sodium. The solution is pH-adjusted to 6.0 - 7.6 with sodium hydroide and contains approximately 4.8 mg sodium and 367 mg organically bound iodine. It is used for gastrointestinal radiography and should be discarded if unused. The solution should be protected from light, stored at 20-25°C (68-77°F), and dispensed in tight light-resistant containers. The manufacturer is the Guardian Drug Company located in Dayton, New Jersey. Lot and Exp information is provided but not readable in the text.*

This is a single dose bottle of Diatrizoate Meglumine and Diatrizoate Sodium solution, with an organically bound iodine concentration of 37%. It is intended for gastrointestinal radiography, and is not meant for parenteral use. The dosage is specified in the package insert. Each mL contains 660 mg of Diatrizoate Meglumine and 100 g of Diatrizoate Sodium, with a pH adjusted between 6.0 and 7.6 using Sodium hydroxide. The solution contains approximately 4.8 mg (0.21 MEq) of sodium and 367 5 mg of organically bound iodine. It is only suitable for oral or rectal use, and should be protected from light and stored at 20-25°C (68-77°F) in a tight, light-resistant container. Unused portions should be discarded. This product is manufactured by Guaranty company and it's only available by prescription in a 30mL bottle.*

Not available. The text seems to be a collection of fragmented sentences and phrases of medical terms and instructions, as well as alphanumeric codes and manufacturing information that do not make sense in context.*

This is a description of a medical solution used for gastrointestinal radiography. The solution contains diatrizoate meglumine and diatrizoate sodium and is for oral or rectal use only. Each milliliter of the solution contains 660 mg diatrizoate meglumine and 100 mg diatrizoate sodium, as well as approximately 4.8 mg (0.21 mEq) sodium and 37% organically bound iodine. The solution should be stored at room temperature, protected from light, and discarded if not used. This product is not for injection and is manufactured by Guardian D Company. Dosage information can be found in the package insert.*

This is a medication with the NDC code 53041-690-03. It is a solution of Diatrizoate Meglumine and Diatrizoate Sodium, to be used for oral or rectal administration only. It is not for household dispensing and should be discarded if unused. The medication is intended for gastrointestinal radiography, not for parenteral use. Each mL of the solution contains 660 mg of diatrizoate meglumine, 100 mg diatrizoate sodium, and approximately 367 mg of organically bound iodine. It is protected from light and should be stored at a temperature of 20-25°C. The manufacturer is the Guardian Drug Company. The description does not indicate the medical condition for which the medication may be prescribed.*